Sodium thiosulfate for prevention of cisplatin-induced hearing loss: updated survival from ACCL0431

Lancet Oncol. 2022 May;23(5):570-572. doi: 10.1016/S1470-2045(22)00155-3.
No abstract available

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cisplatin* / adverse effects
  • Hearing Loss* / chemically induced
  • Hearing Loss* / prevention & control
  • Humans
  • Thiosulfates / therapeutic use

Substances

  • Thiosulfates
  • sodium thiosulfate
  • Cisplatin